Therapeutic Asset Ratings
3,774 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Lifileucel
Undifferentiated High Grade Pleomorphic Sarcoma Of Bone
M.D. Anderson Cancer Center
P2
CCC
(53)
Liocyx-M
Liver Cancer
Lion TCR Pte. Ltd.
P2
CCC
(53)
Mb-Cart19.1
Non-Hodgkin Lymphoma
King Hussein Cancer Center
P2
CCC
(53)
MEMORY CYTOKINE-ENHANCED NK CELLS
Prostate Cancer
ImmunityBio, Inc.
P2
CCC
(53)
MEMORY CYTOKINE-ENHANCED NK CELLS
Ovarian Cancer
ImmunityBio, Inc.
P2
CCC
(53)
Mnv-201
Mitochondrial Disease
Minovia Therapeutics Ltd.
P2
CCC
(53)
Mnv-201
Pearson Syndrome
Minovia Therapeutics Ltd.
P2
CCC
(53)
mt027 car-t cells
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
T-MAXIMUM Pharmaceutical Inc
P2
CCC
(53)
Pank-003 Cell
Non-Small Cell Lung Carcinoma
Shenzhen Celconta Life Science Co., Ltd.
P2
CCC
(53)
Pbsc
Fanconi Anemia
Children's Hospital Medical Center, Cincinnati
P2
CCC
(53)
Pbsc
Myeloproliferative Neoplasm
Fred Hutchinson Cancer Center
P2
CCC
(53)
Pbsc
Bone Marrow Failure Syndrome
Children's Hospital Medical Center, Cincinnati
P2
CCC
(53)
Pd-L1 T-Hank
Cutaneous Neuroendocrine Carcinoma
ImmunityBio, Inc.
P2
CCC
(53)
Pd-L1 T-Hank
Microsatellite Instability
ImmunityBio, Inc.
P2
CCC
(53)
Pd-L1 T-Hank
Mismatch Repair Deficiency
ImmunityBio, Inc.
P2
CCC
(53)
Rapcabtagene Autoleucel
Diffuse Scleroderma
Novartis Pharmaceuticals
P2
CCC
(53)
Sctil
Gestational Trophoblastic Neoplasm
Peking Union Medical College Hospital
P2
CCC
(53)
Sscart-19
Acute Lymphoblastic Leukemia
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
P2
CCC
(53)
STAPULDENCEL
Fallopian Tube Carcinoma
Peking University Third Hospital
P2
CCC
(53)
STAPULDENCEL
Primary Peritoneal Carcinoma
Peking University Third Hospital
P2
CCC
(53)
Tabelecleucel
Epstein-Barr Virus-Associated Mesenchymal Tumor
Pierre Fabre Medicament
P2
CCC
(53)
Tabelecleucel
Epstein-Barr Virus Infection
Pierre Fabre Medicament
P2
CCC
(53)
Tabelecleucel
Leiomyosarcoma
Pierre Fabre Medicament
P2
CCC
(53)
Tcr Transduced T-Cells
Malignant Endocrine Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Tcr Transduced T-Cells
Gastrointestinal/Genitourinary Cancers
National Cancer Institute (NCI)
P2
CCC
(53)
Showing 376 to 400 of 3,774 assets
Previous
Page 16 of 151
Next